The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 19, 2017
Filed:
Aug. 07, 2015
Applicant:
Viacyte, Inc., San Diego, CA (US);
Inventors:
Laura Martinson, San Diego, CA (US);
Chad Green, San Diego, CA (US);
Evert Kroon, San Diego, CA (US);
Emmanuel Edward Baetge, San Diego, CA (US);
Assignee:
ViaCyte, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/00 (2006.01); A61M 31/00 (2006.01); A61M 37/00 (2006.01); C12N 5/08 (2006.01); A61L 27/38 (2006.01); A61K 35/39 (2015.01); C12N 5/071 (2010.01); A61L 27/14 (2006.01); A61L 27/54 (2006.01); A01N 1/02 (2006.01); A61K 38/28 (2006.01); A61M 5/00 (2006.01); A61F 2/02 (2006.01); A61L 27/50 (2006.01); A61L 27/56 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61L 27/3804 (2013.01); A01N 1/0221 (2013.01); A61F 2/022 (2013.01); A61K 35/39 (2013.01); A61K 38/28 (2013.01); A61L 27/14 (2013.01); A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61M 5/00 (2013.01); A61M 31/002 (2013.01); C12N 5/0676 (2013.01); C12N 5/0678 (2013.01); A61K 2035/126 (2013.01); A61L 2300/252 (2013.01); A61L 2300/62 (2013.01); A61L 2300/64 (2013.01); A61M 31/00 (2013.01); A61M 2202/07 (2013.01); A61M 2205/04 (2013.01); C12N 2501/115 (2013.01); C12N 2501/117 (2013.01); C12N 2501/119 (2013.01); C12N 2501/16 (2013.01); C12N 2501/19 (2013.01); C12N 2501/385 (2013.01); C12N 2501/41 (2013.01); C12N 2501/415 (2013.01); C12N 2506/02 (2013.01);
Abstract
The present invention relates to methods for encapsulating pancreatic progenitors in a biocompatible semi-permeable encapsulating device. The present invention also relates to production of human insulin in a mammal in response to glucose stimulation.